SPIT SEQ - Revolutionizing Drug Resistance Testing for Tuberculosis
What is SPIT SEQ?
The NGS-based whole genome sequencing test rapidly and accurately identifies drug-resistant Mycobacterium tuberculosis from both pulmonary and extra-pulmonary clinical samples, transforming TB treatment by enabling precise and timely interventions.
Understanding Drug- Resistant Tuberculosis
Drug-resistant tuberculosis (TB) arises when TB bacteria become immune to standard treatments, often due to improper antibiotic use or incomplete regimens, or transmission of resistant strains
Managing drug-resistant TB is challenging, requiring longer, costlier treatments with more severe side effects. Accurate diagnosis, strict treatment adherence, and robust infection control are essential for effective management.
Why Drug Resistance Testing is Essential?
- Accurate Diagnosis: Identifies specific drug-resistant
TB strains, ensuring precise treatment. - Effective Treatment: Guides the use of appropriate medications, improving patient outcomes.
- Prevention of Spread: Helps contain the transmission
of resistant strains. - Resource Optimization: Reduces the misuse of ineffective drugs, saving healthcare resources.
- Improved Prognosis: Enables timely intervention, reducing complications and mortality rates.
Choose SPIT SEQ by Medgenome: The benchmark in drug resistance TB testing.
Detects DR-TB directly from both pulmonary and extra-pulmonary samples accurately and swiftly.
Predicts resistance for 18+ TB drugs, providing extensive diagnostic insights.
Receive detailed reports within 14 days, ensuring timely and personalized treatment initiation.
Offers the most precise testing for first-line, second line, and newer TB drugs, more economical than phenotype testing.
Proven reliability through extensive peer-reviewed publications.
Outperforms amplicon-based tests by sequencing the entire TB genome.
Provides comprehensive information on heteroresistance and TB strain lineage for optimal treatment strategies.
FAQ
SPIT SEQ, the direct sputum based whole genome sequencing test for Mtb is validated with 100 samples
| Sensitivity | 100% compared to LPA as reference standard |
| Specificity | 98.04% compared to LPA as reference standard |
Enquire
Now 